You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 19, November 19, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letter
 •Similar articles in JAMA
 Topic Collections
 •Aging/ Geriatrics
 •Endocrine Diseases
 •Diabetes Mellitus
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Association of Fetuin-A Level and Diabetes Risk

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In the case-cohort study of participants in the Health, Aging, and Body Composition (ABC) Study, Dr Ix and colleagues1 found that higher circulating levels of the liver-derived protein fetuin-A were associated with increased risk of developing type 2 diabetes in older individuals. Although fetuin-A was positively correlated with the amount of visceral fat assessed by computed tomographic scanning, the relationship to incident diabetes was only marginally attenuated after adjustment for visceral adiposity. Adjustment for the circulating adipokines adiponectin and leptin, as well as for circulating cytokines, did not affect the results, suggesting an independent effect of fetuin-A on diabetes risk.

In agreement with these findings, the European Prospective Investigation into Cancer and Nutrition (EPIC)–Potsdam cohort study found that high levels of fetuin-A were positively associated with diabetes risk after adjustment for body mass index, waist circumference, {gamma}-glutamyltransferase, high sensitivity C-reactive protein levels, and other lifestyle and metabolic . . . [Full Text of this Article]

Norbert Stefan, MD
norbert.stefan@med.uni-tuebingen.de

Hans-Ulrich Häring, MD
Department of Internal Medicine
Division of Endocrinology, Diabetology, Vascular Medicine, Nephrology and Clinical Chemistry
University of Tübingen
Tübingen, Germany

Matthias B. Schulze, DRPH
Public Health Nutrition Unit
Center of Life and Food Sciences Weihenstephan
Technische Universität München
Munich, Germany



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED ARTICLE

Fetuin-A and Incident Diabetes Mellitus in Older Persons
Joachim H. Ix, Christina L. Wassel, Alka M. Kanaya, Eric Vittinghoff, Karen C. Johnson, Annemarie Koster, Jane A. Cauley, Tamara B. Harris, Steven R. Cummings, Michael G. Shlipak, and for the Health ABC Study
JAMA. 2008;300(2):182-188.
ABSTRACT | FULL TEXT  

RELATED LETTER

Association of Fetuin-A Level and Diabetes Risk—Reply
Joachim H. Ix
JAMA. 2008;300(19):2247-2248.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.